Dr David MAKANJUOLA Renal unit St. Helier hospital

Slides:



Advertisements
Similar presentations
Detection, monitoring and referral of chronic kidney disease
Advertisements

Assesment of renal function in case of near normal creatinine (<1
Streatham & Clapham Health Renal Outreach Clinic
AKI in Pediatrics Patrick D. Brophy MD Associate Professor
Chronic kidney disease
Chronic kidney disease
Paediatric Nephrology
Hisham Abdelwahab MRCP U.K MMed/SCI
Proteinuria and Haematuria – an update Alex Heaton
CKD ML/LH What are people hoping to cover from the session today?
Diabetes and Renal Disease. PACE guidelines for Diabetes 2002 Renal/Hypertension.
Chronic Renal Failure for General Practice
Egyptian Guidelines For Management of Chronic Hepatitis B
Update in the management of AKI
Algorithm Dr. Patrice Junod Clinique médicale l’Actuel This activity is supported by an educational grant from:
Case Study This activity is supported by an educational grant from: Aging Woman with longstanding HIV and multiple comorbidities Dr. Gord Arbess.
Chronic Kidney Disease Manju Sood GPST3. What is CKD? Chronic renal failure is the progressive loss of nephrons resulting in permanent compromise of renal.
The ACOG Task force on hypertension in pregnancy
Prepared by D. Chaplin Chronic Renal Failure. Prepared by D. Chaplin Chronic Renal Failure Progressive, irreversible damage to the nephrons and glomeruli.
Chronic kidney disease: [insert title here] Insert name, title, date here Insert acknowledgements here.
FY1 Teaching Nov 30th 2011 Dr Jack Bond ST5 Nephrology
Recent Advances in Management of CRF Yousef Boobess, M.D. Head, Nephrology Division Tawam Hospital.
Myeloma and Renal Disease
CKD 1-5d GFR Stages Complications Referral Access/ESRD  Thomas Schumacher.
General Practice Workshop This workshop was conceived and developed by Kidney Health Australia’s Kidney Check Australia Taskforce with particular thanks.
Urinary tract infections … I can’t wait…. Symptoms of UTI: Dysuria, frequency, urgency, suprapubic tenderness, haematuria, polyuria.
Efficacy of Sodium Bicarbonate Infusion in Reversal of Acute Renal Failure 1 NEPHRO 2014 June 25-28, 2014 Valencia, Spain.
CKD In Primary Care Dr Mohammed Javid.
National Institute for Health and Clinical Excellence.
Ken Chow. What is haematuria?  Macroscopic Visible haematuria Pink or red  Microscopic Gold standard – Microscopy ○ Presence of >3 RBCs per high-powered.
Chronic Kidney Disease NICE Guidelines 2008 Dr Jennifer Kuo Dr Naeema Rashid Dr Shamita Das.
This lecture was conducted during the Nephrology Unit Grand Ground by Medical Student rotated under Nephrology Division under the supervision and administration.
Chronic Kidney Disease Workshop Maarten Taal Department of Renal Medicine Derby City General Hospital Derby Nephrology Research.
Case Presentation Dr Mohan Shenoy Consultant Paediatric Nephrologist Royal Manchester Children’s Hospital.
Potassium Disorders Ganesh Shidham, MD Associate Professor of Internal Medicine Division of Nephrology.
Renal Function Tests. Assessing the Kidney The Kidney The StructureThe Function Structure and function are not completely independent Some tests give.
The laboratory investigation of urinary tract infections
Diabetic Nephropathy Case Presentations. UA (Urine Dipstick) Use as an initial screen for all patients Negative to trace proteinuria requires further.
A significant proportion of diabetic patients develop diabetic nephropathy which can eventually progress to end-stage renal disease despite established.
Polycystic Kidney Disease Jeffrey Zhao. Two Types  Genetic Disorder  Occurs in humans a few mammals  Around 12.5 million people worldwide  Autosomal.
CKD: the primary/secondary care interface Daniel Ford Consultant Renal Physician UHCW.
Diabetic Nephropathy Yiming Lit, M.D. May 5, 2009.
EPIDEMIOLOGY Epidemiology of chronic kidney injury, including prevalence and prognosis in various community groups. Screening of populations for kidney.
Adult Polycystic Kidney Disease.  Autosomal dominant  1-2 per 1000  Cysts present at birth, progressively enlarge to compress renal parenchyma  Occurs.
Source: Site Name and Year IHS Diabetes Audit Diabetes Health Status Report ______Site Name_________ Health Outcomes and Care Given to Patients with Diabetes.
The National Kidney Foundation’s Kidney Early Evaluation Program TM “The Greater New York Experience” Ellen H. Yoshiuchi, MPS Division Program Director.
Section 6: Management in primary care Particular emphasis on nurse practitioner’s role.
If I had Chronic Kidney Disease: What would I want my Doctor to Know….. Liam Plant Department of Renal Medicine, Cork University Hospital Department of.
10/2/2015 AQEEL ALGHAMDI 1. PROTEINURIA DR AQEEL ALGHAMDI MBBS,DCH,JBCP,ABP,FBN consultant pediatric nephrology 10/2/20152.
AKI (formerly ARF) 13–18% of all people admitted to hospital.
Renal Referrals at UHB Mark Jesky Research Registrar.
CYSTIC DISEASE OF KIDNEY Dr S Chakradhar 1. Classification of renal cyst Adult polycystic disease (Autosomal dominant disease) Adult polycystic disease.
Dr M Sivalingam Renal Unit, Lister Hospital, Stevenage.
Case Report and Lit Review: Reduction of Proteinuria in Diabetic Nephropathy with Spironolactone Harry W. Floyd, M.D. Family Medicine Kingstree, South.
Objectives Understand why AKI matters Natural history Associated risk Be able to recognise AKI Do small changes in creatinine/eGFR really matter? Be confident.
Dr. Aya M. Serry Renal Failure Renal failure is defined as a significant loss of renal function in both kidneys to the point where less than 10.
بسم الله الرحمن الرحيم. POLYCYSTIC KIDNEY DISEASE Lecture by: Dr. Zaidan Jayed Zaidan.
MEERA LADWA ACUTE KIDNEY INJURY. WHAT IS ACUTE KIDNEY INJURY? A rapid fall in glomerular filtration rate (GFR) In practice, since measuring GFR is difficult,
Microscopic Haematuria. Transient Causes Transient –UTI –Exercise Spurious –Menstrual contamination –Sexual intercourse.
Acute Kidney Injury (AKI) Based on NICE Guidelines Tariq Rehman Consultant Physician.
Dr.Ruba Nashawati. Diabetes  Leading cause of ESRD  30% 40%  DN  DN Risk type I = type II.
NICE Chronic Kidney Disease (CKD) Guidance 2014 Chronic kidney disease in adults: assessment and management (CG182)
Gilead -Topics in Human Pathophysiology Fall 2009 Drug Safety and Public Health.
Key facts about AKI 5 Facts about acute kidney injury (AKI), formerly known as "acute renal failure“ Up to 20% of hospital admissions have AKI Up to 25%
Section 6: Management in primary care
Adult polycystic kidney disease
Renal Pharmacy Group Beginners Lectures 2018
Diuretics, Kidney Diseases Urine R&M
IgA Nephropathy Southwest Nephrology Symposium February 24th 2018.
Consultant Clinical Biochemist
Presentation transcript:

Dr David MAKANJUOLA Renal unit St. Helier hospital Renal disease Dr David MAKANJUOLA Renal unit St. Helier hospital

Case history 22 year old Afro-Caribbean male Microscopic haematuria noted on registration with new GP. No proteinuria Normal creatinine (90µmol/l) Blood pressure 120/70mmHg No haematuria on dipstick testing at subsequent review in GP surgery.

Management should include Haematuria Management should include Check serum creatinine in all patients Check for proteinuria in all patients (quantitate protein/creatinine ratio if positive) Invisible (microscopic) haematuria without proteinuria, GFR>60ml/min/1.73m2 Microscopic haematuria with prot/creat ratio >50mg/mmol Visible (macroscopic) haematuria

Major causes of haematuria by age and duration From Up To Date Schematic representation of the major causes of haematuria in relation to the age at which they usually occur (horizontal axis), transience or persistence (vertical axis), and frequency (blue implies more frequent).

Management should include Check serum creatinine in all patients Haematuria Management should include Check serum creatinine in all patients Check for proteinuria in all patients (quantitate protein/creatinine ratio if positive) Visible (macroscopic) haematuria Invisible (microscopic) haematuria without proteinuria, GFR>60ml/min/1.73m2 Microscopic haematuria with prot/creat ratio >50mg/mmol Usually fast track Urology referral for imaging and cystoscopy, unless strong pointers to acute renal disease Refer to nephrology if urological investigations negative Age >40, usually refer to Urology (recommended age may vary locally) Age <40, or >40 with negative urological investigations, manage as Stage 1/2 CKD Refer to nephrology Lower levels of proteinuria, manage as Stage 1/2 CKD

Microscopic haematuria Refer to renal team. Management should include Check serum creatinine in all patients Check for proteinuria in all patients (quantitate protein/creatinine ratio if positive) Microscopic haematuria with GFR>60ml/min/1.73m2 (+/-prot/creat ratio >50mg/mmol) Refer to renal team. Visible (macroscopic) haematuria Invisible (microscopic) haematuria without proteinuria, GFR>60ml/min/1.73m2 Microscopic haematuria with prot/creat ratio >50mg/mmol Usually fast track Urology referral for imaging and cystoscopy, unless strong pointers to acute renal disease Refer to nephrology if urological investigations negative Age >40, usually refer to Urology (recommended age may vary locally) Age <40, or >40 with negative urological investigations, manage as Stage 1/2 CKD Refer to nephrology Lower levels of proteinuria, manage as Stage 1/2 CKD

Case history Plan - manage as stage 1/2 CKD. Poor attender at surgery. Develops flu-like illness with abdominal pain. Gives history of intermittent flank pains, but no dysuria or history of renal stones.

Case history Haematuria on dipstick testing on this occasion, but also, protein 1+, nitrites and leucocytes +ve. BP 150/110mmHg MSU sent. Form given for blood tests. Commenced on Trimethoprim

Case history Blood tests while on antibiotics show the following: Hb 15 Urea 6.5 WBC 13.5 Creatinine 135 Platelets 225 Potassium 5.3 CRP 68 MSU – WCC > 100, RBC + Coliforms, sens to Trimethoprim, Amoxycillin

A digression……… Trimethoprim inhibits the secretion of creatinine into the tubules and can reversibly increase the serum creatinine up to 10-15%. CREATININE (~10-15%) UREA (variable %)

Another digression………

Mineralocorticoid receptor Tubular lumen Tubular cell Blood 3 Na+ Na K ATPase Na+ ENaC 2 K+ Na+ Na+ Na+ Mineralocorticoid receptor

Mineralocorticoid receptor Tubular lumen Tubular cell Blood 3 Na+ Na K ATPase Na+ Na+ ENaC 2 K+ Na+ Na+ Na+ Mineralocorticoid receptor

Mineralocorticoid receptor Tubular lumen Tubular cell Blood 3 Na+ Na K ATPase Na+ Na+ ENaC 2 K+ Na+ K+ Na+ K+ Na+ Mineralocorticoid receptor

Mineralocorticoid receptor Tubular lumen Tubular cell Blood 3 Na+ Na K ATPase Na+ Na+ ENaC 2 K+ Na+ Na+ Na+ Aldosterone Mineralocorticoid receptor Aldosterone

Mineralocorticoid receptor Tubular lumen Tubular cell Blood 3 Na+ Na K ATPase Na+ Na+ ENaC 2 K+ Na+ ENaC Na+ Na+ Aldosterone Aldosterone Mineralocorticoid receptor

Mineralocorticoid receptor Tubular lumen Tubular cell Blood 3 Na+ Na K ATPase Na+ Na+ ENaC 2 K+ Na+ ENaC Na+ K+ Hypertension Na+ Na+ K+ Na+ Na+ Aldosterone Aldosterone Mineralocorticoid receptor K+ K+ K+ Hypokalaemia

Mineralocorticoid receptor Tubular lumen Tubular cell Blood 3 Na+ Na K ATPase Na+ Na+ ENaC 2 K+ Na+ ENaC Na+ K+ Na+ Na+ K+ Na+ Na+ Aldosterone Aldosterone Mineralocorticoid receptor Spironolactone K+ K+ K+

Mineralocorticoid receptor Tubular lumen Tubular cell Blood 3 Na+ Na K ATPase Na+ Na+ ENaC 2 K+ ENaC Na+ K+ Na+ K+ Lower BP Na+ K+ Na+ Aldosterone Aldosterone Mineralocorticoid receptor Spironolactone Hyperkalaemia

Mineralocorticoid receptor Tubular lumen Tubular cell Blood 3 Na+ Na K ATPase Na+ Na+ ENaC 2 K+ Na+ ENaC Na+ K+ Hypertension Na+ Na+ K+ Na+ Na+ Aldosterone Aldosterone Mineralocorticoid receptor K+ K+ K+ Hypokalaemia

Mineralocorticoid receptor Tubular lumen Tubular cell Blood 3 Na+ Na K ATPase Na+ Amiloride ENaC 2 K+ Na+ ENaC K+ Na+ K+ Na+ Aldosterone Aldosterone Mineralocorticoid receptor

Mineralocorticoid receptor Tubular lumen Tubular cell Blood 3 Na+ Na K ATPase Na+ Amiloride ENaC 2 K+ Na+ ENaC K+ Na+ K+ Na+ Aldosterone Aldosterone Mineralocorticoid receptor Triamterene and Trimethoprim also work in a similar fashion

Case history Blood tests repeated 1 week after the course of antibiotics show the following: Hb 15 Urea 6.5 WBC 6.5 Creatinine 150 Platelets 225 Potassium 5.3 CRP 5 Urine dipstick – blood 2+

Acute Kidney Injury (AKI) Acute kidney injury is defined when one of the following criteria is met: Serum creatinine rises by ≥ 26µmol/L within 48 hours or

Acute Kidney Injury (AKI) Acute kidney injury is defined when one of the following criteria is met: Serum creatinine rises by ≥ 26µmol/L within 48 hours or Serum creatinine rises ≥ 1.5 fold from the known reference value*, or The rise in serum creatinine of ≥ 1.5 is presumed to have occurred within one week or

Acute Kidney Injury (AKI) Acute kidney injury is defined when one of the following criteria is met: Serum creatinine rises by ≥ 26µmol/L within 48 hours or Serum creatinine rises ≥ 1.5 fold from the reference value, which is known or The rise in serum creatinine of ≥ 1.5 is presumed to have occurred within one week or Urine output is < 0.5ml/kg/hr for >6 consecutive hours

Acute Kidney Injury (AKI) The reference serum creatinine should be the lowest creatinine value recorded within 3 months of the event. If a reference serum creatinine value is not available within 3 months and AKI is suspected, repeat the serum creatinine within 24 hours. A reference serum creatinine value can be estimated from the nadir serum creatinine value if the patient recovers from AKI.

AKI - classification Stage Serum creatinine (SCr) criteria Urine output criteria 1 increase of ≥ 26 μmol/L within 48h or increase of ≥1.5 to 1.9 X reference SCr <0.5 mL/kg/hr for > 6 consecutive hrs

AKI - classification Stage Serum creatinine (SCr) criteria Urine output criteria 1 increase of ≥ 26 μmol/L within 48h or increase of ≥1.5 to 1.9 X reference SCr <0.5 mL/kg/hr for > 6 consecutive hrs 2 increase of ≥ 2 to 2.9 X reference SCr <0.5 mL/kg/ hr for > 12 h

AKI - classification Stage Serum creatinine (SCr) criteria Urine output criteria 1 increase ≥ 26 μmol/L within 48h or increase ≥1.5 to 1.9 X reference SCr <0.5 mL/kg/hr for > 6 consecutive hrs 2 increase of ≥ 2 to 2.9 X reference SCr <0.5 mL/kg/ hr for > 12 h 3 increase of ≥3 X reference SCr or increase of ≥354 μmol/L or commenced on renal replacement therapy (RRT) irrespective of stage <0.3 mL/kg/ hr for > 24 h anuria for 12 hrs

Possible outcomes from AKI Cerda, J. et al. Clin J Am Soc Nephrol 2008;3:881-886

Case history Auto-immune screen –ve Hb electrophoresis normal Vasculitis screen –ve Abdominal ultrasound scan shows multiple cysts in both kidneys, as well as some cysts in the liver. Family history – no known FH of CKD, but his father died in his 40s of a stroke.

Polycystic kidneys

Polycystic kidneys Epidemiology Genetics Clinical features Diagnosis Treatment

Polycystic kidneys - Epidemiology Common – occurs in 1 in every 400-1,000 live births. Family history - can be negative in up to 25% of cases: New mutation Adopted individual Affected parent died without PKD being noted

Polycystic kidneys - Genetics Autosomal recessive PKD Predominantly a disease of childhood. Much less common than autosomal dominant PKD.

Polycystic kidneys - Genetics Autosomal dominant (adult) PKD PKD 1 – abnormality on chromosome 16 PKD 2 – abnormality on chromosome 4 In PKD 2, development of cysts and also, of ESRD tends to occur later in life and has a less severe phenotype than PKD1.

Polycystic kidneys - Clinical features (Renal) Haematuria – macro and microscopic. Proteinuria – usually <1g/day (PCR 100mg/mmol) Hypertension Renal stones in up to 20% (50%urate stones) Flank and abdominal pains Renal cancers – often bilateral, and frequently present with a fever. diagnosis difficult.

Polycystic kidneys - Clinical features (Extra-renal) Cerebral aneurysms Routine screening is recommended only for high-risk patients, such as those with: a previous rupture a positive family history of an intra-cerebral bleed or intracranial aneurysm warning symptoms a high-risk occupation in which loss of consciousness would place the patient or others at extreme risk and prior to surgery that is likely to be associated with hemodynamic instability with hypertension

Polycystic kidneys - Clinical features (Extra-renal) Hepatic cysts Pancreatic cysts Diverticular disease Epididymal cysts Herniae Cardiac disease – Mitral valve prolapse Aortic regurgitation

Polycystic kidneys - Diagnosis Ultrasonography Best not to do it in people under the age of 18: Possibility of false negative scan especially with PKD2 Adverse consequences – emotional, career, insurance, etc. outweigh benefits of early diagnosis, especially as there is no curative treatment.

Polycystic kidneys - Diagnosis Ultrasonographic criteria: Positive family History of PKD Age Criteria 15-39 At least 3 unilateral or bilateral cysts 40-59 At least 2 cysts in each kidney >60 At least 4 cysts in each kidney

Polycystic kidneys - Diagnosis Ultrasonographic criteria: Negative family Hx of PKD – difficult. Suspect it if there are > 10 cysts in each kidney, especially if the kidneys are large, and/or there are also liver cysts.

Polycystic kidneys - Treatment Hypertension Statins Vasopressin receptor antagonists mTOR inhibitors e.g Sirolimus, Everolimus Caffeine restriction Dialysis and Transplantation

REFERENCES http://www.renal.org/Clinical/GuidelinesSection/ UpToDate